ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Metabolomics toward personalized medicine

Jacob, Minnie; Lopata, Andreas L.; Dasouki, Majed; Rahman, Anas M. Abdel*
Mass Spectrometry Reviews2019-5DOI: 10.1002/mas.21548
236被引2阅读
引用收藏
分享

摘要

Metabolomics, which is the metabolites profiling in biological matrices, is a key tool for biomarker discovery and personalized medicine and has great potential to elucidate the ultimate product of the genomic processes. Over the last decade, metabolomics studies have identified several relevant biomarkers involved in complex clinical phenotypes using diverse biological systems. Most diseases result in signature metabolic profiles that reflect the sums of external and internal cellular activities. Metabolomics has a major role in clinical practice as it represents >95% of the workload in clinical laboratories worldwide. Many of these metabolites require different analytical platforms, such as Nuclear Magnetic Resonance (NMR), Mass Spectrometry (MS), and Ultra Performance Liquid Chromatography (UPLC), while many clinically relevant metabolites are still not routinely amenable to detection using currently available assays. Combining metabolomics with genomics, transcriptomics, and proteomics studies will result in a significantly improved understanding of the disease mechanisms and the pathophysiology of the target clinical phenotype. This comprehensive approach will represent a major step forward toward providing precision medical care, in which individual is accounted for variability in genes, environment, and personal lifestyle. In this review, we compare and evaluate the metabolomics strategies and studies that focus on the discovery of biomarkers that have "personalized" diagnostic, prognostic, and therapeutic value, validated for monitoring disease progression and responses to various management regimens.

学科与关键词

关键词
biomarker discoverycancer metabolomicsclinical metabolomicsinborn errors of metabolismmass spectrometrymetabolomics
相关
加载中…
  • The role of metabolites and metabolomics in clinically applicable biomarkers of disease
    Mamas, Mamas; Dunn, Warwick B.; Neyses, Ludwig; Goodacre, Royston*Archives of Toxicology, 2011, 85(1): 5-17.被引 275
  • Metabolomics: a tool for personalizing medicine?
    Schnackenberg, Laura K.*; Kaput, Jim; Beger, Richard D.Personalized Medicine, 2008, 5(5): 495-504.被引 7
  • The promise of metabolic phenotyping in gastroenterology and hepatology
    Holmes, Elaine; Wijeyesekera, Anisha; Taylor-Robinson, Simon D.; Nicholson, Jeremy K.*Nature Reviews. Gastroenterology and Hepatology, 2015, 12(8): 458-471.被引 61
查看全部 →

发表信息

论文状态
公开发表
期刊
Mass Spectrometry Reviews
发表日期
2019-05
卷期
第 38 卷, 第 3 期
页码
221-238
DOI
10.1002/mas.21548
语言
ENGLISH
成果收录
SCIE

作者

  • J

    Jacob, Minnie (第一作者)

  • L

    Lopata, Andreas L.

查看全部 4 位作者收起作者
  • D

    Dasouki, Majed

  • R

    Rahman, Anas M. Abdel (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417